These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 24938314)
1. Insulin detemir treatment in diabetic cats in a practice setting. Hoelmkjaer KM; Spodsberg EM; Bjornvad CR J Feline Med Surg; 2015 Feb; 17(2):144-51. PubMed ID: 24938314 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control. Roomp K; Rand J J Feline Med Surg; 2012 Aug; 14(8):566-72. PubMed ID: 22553309 [TBL] [Abstract][Full Text] [Related]
3. Feline diabetes mellitus: clinical use of long-acting glargine and detemir. Bloom CA; Rand J J Feline Med Surg; 2014 Mar; 16(3):205-15. PubMed ID: 24563492 [TBL] [Abstract][Full Text] [Related]
4. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus. Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419 [TBL] [Abstract][Full Text] [Related]
5. ISFM consensus guidelines on the practical management of diabetes mellitus in cats. Sparkes AH; Cannon M; Church D; Fleeman L; Harvey A; Hoenig M; Peterson ME; Reusch CE; Taylor S; Rosenberg D; J Feline Med Surg; 2015 Mar; 17(3):235-50. PubMed ID: 25701862 [TBL] [Abstract][Full Text] [Related]
6. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus. Hemmingsen B; Metzendorf MI; Richter B Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013498. PubMed ID: 33662147 [TBL] [Abstract][Full Text] [Related]
7. Detemir improves diabetic regulation in poorly controlled diabetic dogs with concurrent diseases. Harris-Samson AR; Rand J; Ford SL J Am Vet Med Assoc; 2023 Jan; 261(3):327-335. PubMed ID: 36656678 [TBL] [Abstract][Full Text] [Related]
8. Management of diabetic cats with long-acting insulin. Roomp K; Rand JS Vet Clin North Am Small Anim Pract; 2013 Mar; 43(2):251-66. PubMed ID: 23522171 [TBL] [Abstract][Full Text] [Related]
10. Observational 6-month open-label study of Japanese type 2 diabetes patients switching from NPH insulin to insulin detemir in basal-bolus regimen: 23rd article of the Japan Diabetes Clinical Data Management Study Group (JDDM23). Oishi M; Abe N; Yokoyama H; Kuribayashi N; Tomonaga O; Matoba K; Kobayashi M; J Int Med Res; 2012; 40(2):787-97. PubMed ID: 22613444 [TBL] [Abstract][Full Text] [Related]
11. Frequency of diabetic remission, predictors of remission and survival in cats using a low-cost, moderate-intensity, home-monitoring protocol and twice-daily glargine. Gottlieb S; Rand JS; Anderson ST J Feline Med Surg; 2024 Apr; 26(4):1098612X241232546. PubMed ID: 38661475 [TBL] [Abstract][Full Text] [Related]
12. The effect of Insulin Degludec on glycemic control in diabetic cats over a 12-month period. Oda H; Mori A; Sako T J Vet Med Sci; 2020 Jun; 82(6):695-698. PubMed ID: 32307342 [TBL] [Abstract][Full Text] [Related]
13. [RESOLUTE Study in the Czech Republic: insulin glargine improves the compensation of type 2 diabetes in patients with unsatisfactory results of therapy with a combination of insulin detemir and oral antidiabetics. Results of the nonintervention RESOLUTE Project in the Czech Republic]. Kvapil M Vnitr Lek; 2013 Sep; 59(9):800-6. PubMed ID: 24073952 [TBL] [Abstract][Full Text] [Related]
14. Control of diabetes mellitus in cats with porcine insulin zinc suspension. Martin GJ; Rand JS Vet Rec; 2007 Jul; 161(3):88-94. PubMed ID: 17652434 [TBL] [Abstract][Full Text] [Related]
15. Intensive blood glucose control is safe and effective in diabetic cats using home monitoring and treatment with glargine. Roomp K; Rand J J Feline Med Surg; 2009 Aug; 11(8):668-82. PubMed ID: 19592286 [TBL] [Abstract][Full Text] [Related]
16. Comparisons of different measurements for monitoring diabetic cats treated with porcine insulin zinc suspension. Martin GJ; Rand JS Vet Rec; 2007 Jul; 161(2):52-8. PubMed ID: 17630418 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats. Nelson RW; Lynn RC; Wagner-Mann CC; Michels GM J Am Vet Med Assoc; 2001 Jan; 218(1):38-42. PubMed ID: 11149712 [TBL] [Abstract][Full Text] [Related]
18. Long-acting insulin analogue detemir compared with NPH insulin in type 1 diabetes: a systematic review and meta-analysis. Szypowska A; Golicki D; Groele L; Pańkowska E Pol Arch Med Wewn; 2011; 121(7-8):237-46. PubMed ID: 21878861 [TBL] [Abstract][Full Text] [Related]
19. Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study. Damci T; Emral R; Svendsen AL; Balkir T; Vora J; BMC Endocr Disord; 2014 Jul; 14():61. PubMed ID: 25048824 [TBL] [Abstract][Full Text] [Related]
20. PREDICTIVE- a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort. Lüddeke HJ; Sreenan S; Aczel S; Maxeiner S; Yenigun M; Kozlovski P; Gydesen H; Dornhorst A; Diabetes Obes Metab; 2007 May; 9(3):428-34. PubMed ID: 17391171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]